These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 30646013

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition.
    Chen J, Li F, Xu Y, Zhang W, Hu Y, Fu Y, Xu W, Ge S, Fan X, Lu L.
    Exp Eye Res; 2019 Jul; 184():64-71. PubMed ID: 30898556
    [Abstract] [Full Text] [Related]

  • 23. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L, Fan Y, Wang F, Gu Q, Xu X.
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.
    Li Q, Hua X, Li L, Zhou X, Tian Y, Deng Y, Zhang M, Yuan X, Chi W.
    Cell Commun Signal; 2022 May 06; 20(1):59. PubMed ID: 35524333
    [Abstract] [Full Text] [Related]

  • 28. Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
    Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F.
    Clin Exp Ophthalmol; 2007 Nov 06; 35(8):745-8. PubMed ID: 17997779
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
    Shen M, Yuan F, Jin J, Yuan Y.
    Ophthalmic Res; 2014 Nov 06; 52(1):17-24. PubMed ID: 24853648
    [Abstract] [Full Text] [Related]

  • 31. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P, Li L, Liu G, Zhang X, Mukaida N.
    Invest Ophthalmol Vis Sci; 2009 Oct 06; 50(10):4761-8. PubMed ID: 19458323
    [Abstract] [Full Text] [Related]

  • 32. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
    Wang Y, Yin H, Chen P, Xie L, Wang Y.
    Ophthalmic Res; 2011 Oct 06; 46(2):66-72. PubMed ID: 21242701
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
    Yu J, Shen Y, Luo J, Jin J, Li P, Feng P, Guan H.
    Int Immunopharmacol; 2023 Mar 06; 116():109680. PubMed ID: 36739832
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
    Aguirre B, Lin MC, Araujo E, Lu CH, Casero D, Sun M, Nusinowitz S, Hanson J, Calkins K, Gordon L, Wadehra M, Chu A.
    Invest Ophthalmol Vis Sci; 2024 Jul 01; 65(8):10. PubMed ID: 38958972
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A robust model for simultaneously inducing corneal neovascularization and retinal gliosis in the mouse eye.
    Paranthan RR, Bargagna-Mohan P, Lau DL, Mohan R.
    Mol Vis; 2011 Jul 01; 17():1901-8. PubMed ID: 21850164
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of nicotine on corneal wound healing following acute alkali burn.
    Kim JW, Lim CW, Kim B.
    PLoS One; 2017 Jul 01; 12(6):e0179982. PubMed ID: 28644870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.